MedPath

PHENDIMETRAZINE TARTRATE

Phendimetrazine Tartrate Tablets USP, 35 mg CIIIRx only

Approved
Approval ID

577d69c4-35ae-4c2a-b707-b5b353c91b35

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 19, 2019

Manufacturers
FDA

CALVIN, SCOTT AND COMPANY, INCORPORATED

DUNS: 073404626

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PHENDIMETRAZINE TARTRATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17224-501
Application NumberANDA085588
Product Classification
M
Marketing Category
C73584
G
Generic Name
PHENDIMETRAZINE TARTRATE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 9, 2019
FDA Product Classification

INGREDIENTS (8)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
PHENDIMETRAZINE TARTRATEActive
Quantity: 35 mg in 1 1
Code: 6985IP0T80
Classification: ACTIB
FD&C YELLOW NO. 5Inactive
Code: I753WB2F1M
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHENDIMETRAZINE TARTRATE - FDA Drug Approval Details